interstitial lung disease
Showing NaN - NaN of 8
Interstitial Lung Disease Trial in Boston ([68Ga]CBP8, Dotarem)
Recruiting
- Interstitial Lung Disease
-
Boston, MassachusettsMassachusetts General Hospital
Aug 22, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil
Recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
-
Birmingham, Alabama
- +55 more
Aug 16, 2022
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States
Completed
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- Placebo
-
Birmingham, Alabama
- +96 more
Jul 21, 2022
Interstitial Lung Disease Trial in Boston
Recruiting
- Interstitial Lung Disease
-
Boston, MassachusettsPulmonary Care and Research Collaborative, Ltd.
Jul 15, 2022
Patient-Reported Outcome Study of Project ECHO for ILD
Enrolling by invitation
- Interstitial Lung Disease
-
Boston, MassachusettsPulmonary Care and Research Collaborative, Ltd.
Jul 7, 2022
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease Trial in Germany, United States (Bardoxolone
Completed
- Pulmonary Arterial Hypertension
- +11 more
- Bardoxolone methyl
- Placebo
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Scleroderma, Systemic, Sclerosis, Systemic, Systemic Scleroderma Trial in Worldwide (Pomalidomide (CC-4047), Placebo)
Terminated
- Scleroderma, Systemic
- +4 more
- Pomalidomide (CC-4047)
- Placebo
-
Los Angeles, California
- +55 more
Oct 16, 2019
Scleroderma, Interstitial Lung Disease Trial in United States (Mycophenolate mofetil, Cyclophosphamide, Placebo)
Completed
- Scleroderma
- Interstitial Lung Disease
- Mycophenolate mofetil
- +2 more
-
Los Angeles, California
- +13 more
Feb 6, 2017